Allspring Global Investments
ESPR

Allspring Global Investments’s Esperion Therapeutics ESPR Stock Holding History

Allspring Global Investments’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-770
Closed -$1.27K – 1976
2024
Q3 		$1.27K Buy
+770
New +$1.55K ﹤0.01% 2311
2023
Q3 		– Sell
-42,802
Closed -$59.5K – 2815
2023
Q2 		$59.5K Sell
42,802
-162,900
-79% -$227K ﹤0.01% 2245
2023
Q1 		$327K Buy
205,702
+205,296
+50,566% +$1.06M ﹤0.01% 1692
2022
Q4 		$2.53K Buy
+406
New +$2.9K ﹤0.01% 2840

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return